CMS releases ICD-10 codes for new COVID-19 therapies
The Centers for Medicare & Medicaid Services today added 12 new ICD-10 procedure codes to identify new therapies for COVID-19.
These include remdesivir and convalescent plasma, as well as any future COVID-19 therapeutic that does not have a unique name.
CMS also released a new ICD-10 Medicare Severity-Diagnosis Related Group Grouper software package (Version 37.2) to accommodate the new codes, effective for discharges on or after Aug. 1.
The new codes will not affect the MS-DRG assignment.
Related News Articles
Headline
Centers for Medicare & Medicaid Services Administrator Mehmet Oz, M.D., and CMS Deputy Administrator and Director of Medicaid and CHIP Dan Brillman sat…
Headline
Flu and COVID-19 vaccination rates among all health care workers for the 2024-25 respiratory virus season was 76.3% and 40.2%, respectively, according to a…
Headline
A study published March 18 by Science Advances estimated that more than 155,000 U.S. COVID-19 deaths were uncounted during the COVID-19 pandemic. Researchers…
Headline
The Centers for Disease Control and Prevention Feb. 19 released a report on the low use of COVID-19 antiviral drugs among individuals age 65 and older, a…
Headline
The Food and Drug Administration today released two guidance documents; one related to low-risk wellness products (including certain wearable devices) and the…
Headline
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…